These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 314291)
1. Serum complement abnormalities in the antinuclear antibody-positive relatives of children with systemic lupus erythematosus. Lehman TJ; Hanson V; Singsen BH; Kornreich HK; Bernstein B; King KK Arthritis Rheum; 1979 Sep; 22(9):954-8. PubMed ID: 314291 [TBL] [Abstract][Full Text] [Related]
2. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus. Nguyen CP; Cao VV; Fehér J; Gergely P Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790 [TBL] [Abstract][Full Text] [Related]
3. The association of antinuclear antibodies, antilymphocyte antibodies, and C4 activation among the relatives of children with systemic lupus erythematosus. Lehman TJ; Curd JG; Zvaifler NJ; Hanson V Arthritis Rheum; 1982 May; 25(5):556-61. PubMed ID: 6979340 [TBL] [Abstract][Full Text] [Related]
4. Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus. Röther E; Lang B; Coldewey R; Hartung K; Peter HH Clin Rheumatol; 1993 Mar; 12(1):31-5. PubMed ID: 8467609 [TBL] [Abstract][Full Text] [Related]
5. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus. Miyawaki Y; Sada K; Asano Y; Hayashi K; Yamamura Y; Hiramatsu S; Ohashi K; Morishita M; Watanabe H; Matsumoto Y; Kawabata T; Wada J Lupus; 2018 Nov; 27(13):2093-2100. PubMed ID: 30309286 [TBL] [Abstract][Full Text] [Related]
6. Family study of systemic lupus erythematosus: analysis of the clinical history, skin immunofluorescence, and serologic parameters. Lowenstein MB; Rothfield NF Arthritis Rheum; 1977; 20(7):1293-1303. PubMed ID: 334183 [TBL] [Abstract][Full Text] [Related]
7. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus. Davis P; Cumming RH; Verrier-Jones J Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447 [TBL] [Abstract][Full Text] [Related]
8. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis. Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852 [TBL] [Abstract][Full Text] [Related]
9. [Components of the classical complement pathway in systemic lupus erythematosus]. Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498 [TBL] [Abstract][Full Text] [Related]
10. Relationship of clinical findings in systemic lupus erythematosus to seroreactivity. Rothschild BM; Jones JV; Chesney C; Pifer DD; Thompson LD; James KK; Badger H Arthritis Rheum; 1983 Jan; 26(1):45-51. PubMed ID: 6600613 [TBL] [Abstract][Full Text] [Related]
11. [Complement system in disseminated lupus erythematosus]. Vasquez JJ; Fontan G; Gil A; Barbado J; Alvarez I; Ojeda JA Rev Rhum Mal Osteoartic; 1977 Dec; 44(12):725-31. PubMed ID: 76330 [TBL] [Abstract][Full Text] [Related]
12. Familial clustering of non-nuclear autoantibodies and C3 and C4 complement components in systemic lupus erythematosus. Hunnangkul S; Nitsch D; Rhodes B; Chadha S; Roberton CA; Pessôa-Lopes P; Norsworthy PJ; Fernando MM; Charles P; Mackworth-Young C; Isenberg DA; Whittaker JC; Vyse TJ Arthritis Rheum; 2008 Apr; 58(4):1116-24. PubMed ID: 18383369 [TBL] [Abstract][Full Text] [Related]
13. The significance of C3 and C4 complement levels in lupus nephritis. Levo Y; Pick AI Int Urol Nephrol; 1974; 6(3-4):233-8. PubMed ID: 4549215 [No Abstract] [Full Text] [Related]
14. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)]. Dreher R; Helmke K Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508 [No Abstract] [Full Text] [Related]
15. The significance of serial measurement of serum anti-native DNA antibodies and complement C3 and C4 components in the management of patients with systemic lupus erythematosus. Grennan DM; Moseley A; Sloane D; Pumphrey R; Dick WC; Buchanan WW Aust N Z J Med; 1977 Dec; 7(6):625-9. PubMed ID: 306817 [TBL] [Abstract][Full Text] [Related]
16. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products. Lim KL; Jones AC; Brown NS; Powell RJ Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394 [TBL] [Abstract][Full Text] [Related]
17. Anti-CII antibody as a novel indicator to assess disease activity in systemic lupus erythematosus. He C; Mao T; Feng Y; Song T; Qin C; Yan R; Feng P Lupus; 2015 Nov; 24(13):1370-6. PubMed ID: 26048288 [TBL] [Abstract][Full Text] [Related]
18. The value of complement measurements in the assessment of lupus activity. Milis L; Timmermans V; Morris CA; Pussell BA; Charlesworth JA Aust N Z J Med; 1992 Aug; 22(4):338-44. PubMed ID: 1445021 [TBL] [Abstract][Full Text] [Related]
19. Immunological studies in systemic lupus erythematosus. Jin OC; Jacob E; Chua D; Lan YS; Hsii FP J Med Assoc Thai; 1978 Jan; 61 Suppl 1():10-7. PubMed ID: 304878 [No Abstract] [Full Text] [Related]
20. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia. Buyon JP; Cronstein BN; Morris M; Tanner M; Weissmann G Am J Med; 1986 Aug; 81(2):194-200. PubMed ID: 3740078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]